Abstract
The G-7A polymorphism (rs1800801) of the matrix Gla protein (MGP) gene was determined in 170 patients with ischemic atherothrombotic stroke (IATS) and 124 control persons. It was found that the distribution of the major allele homozygotes, heterozygotes, and minor allele homozygotes was 35.9, 48.8, and 15.3% in patients with IATS (in the control, 43.5, 50.0, and 6.5%; P = 0.051 by the χ2 test). Significant differences in the distribution of genotypes were revealed only in women (P = 0.022). The odds ratio (OR) for minor allele homozygotes (A/A) vs. major allele carriers (G/A + G/G) was 2.618 (P = 0.023), while in women it was equal to 6.645 (P = 0.015). In patients with the A/A genotype, the values of the blood coagulation parameters (prothrombin time) indicated increased their predisposition to hypercoagulability. The results obtained prove that the A/A variant of the MGP gene is associated with an increased risk of IATS in females of the Ukrainian population and may be related to blood hypercoagulability and formation of thrombi.
Similar content being viewed by others
References
Allison, M.A. and Wright, C.M., Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1), Int. J. Card., 2005, vol. 98, pp. 325–330.
Detrano, R.C., Wong, N.D., Doherty, T.M., and Shavelle, R., Prognostic significance of coronary calcific deposits in asymptomatic high-risk subjects, Am. J. Med., 1997, vol. 102, pp. 344–349.
Fuessl, H.S., Schalzky, H., Schewe, S., et al., Zur pathogenese und lkinischen bedeutung der mnckebergschen mediaverkalkung, Klin. Wochenschr., 1985, vol. 63, pp. 211–216.
Iribarren, C., Sidney, S., Sternfeld, B., and Browner, W.S., Calcification of the aortic arch: risk factors and association with coronary heart disease stroke, and peripheral vascular disease, J. Am. Med. Assoc., 2000, vol. 283, pp. 2810–2815.
Johnson, R.C., Leopold, J.A., and Loscalzo, J., Vascular calcification. pathobiological mechanisms and clinical implications, Circ. Res., 2006, vol. 99, pp. 1044–10159.
Lehto, S., Niskanen, L., Suhonen, M., et al., Medial artery calcification. a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus, Arterioscler. Thromb. Vasc. Biol., 1996, vol. 16, pp. 978–988.
Wayhs, R., Zelinger, A., and Raggi, P., High coronary artery calcium scores pose and extremely elevated risk for hard events, J. Am. Col. Card, 2002, vol. 39, pp. 225–230.
Price, P.A., Urist, M.R., and Otawara, Y., Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone, Biochem. Biophys. Res. Commun., 1983, vol. 117, pp. 765–771.
Fraser, J.D. and Price, P.A., Lung, heart, and kidney express high levels of mRNA for the vitamin k-dependent matrix Gla protein, J. Biol. Chem., 1988, vol. 263, pp. 11033–11036.
Price, P.A. and Williamson, M.K., Primary structure of bovine matrix Gla protein, a new vitamin k-dependent bone protein, J. Biol. Chem., 1985, vol. 260, pp. 14971–14975.
Cancela, L., Hsiehg, C.-L., Francket, U., and Price, P.A., Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene, J. Biol. Chem., 1990, vol. 265, pp. 15040–15048.
Price, P.A., Faus, S.A., and Williamson, M.K., Warfarin-induced artery calcification is accelerated by growth and vitamin D, Arterioscler. Thromb. Vasc. Biol., 2000, vol. 20, pp. 317–327.
Proudfoot, D. and Shanahan, C.M., Molecular mechanisms mediating vascular calcification: role of matrix Gla protein, Nephrology (Carlton), 2006, vol. 11, pp. 455–461.
Schurgers, L.J., Teunissen, K.J.F., Knapen, M.H.J., et al., Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein, Arterioscler. Thromb. Vasc. Biol., 2005, vol. 25, pp. 1629–1633.
Stanford, W., Coronary artery calcification as an indicator of preclinical coronary artery disease, Radiographics, 1999, vol. 19, pp. 1409–1419.
Shanahan, C.M., Proudfoot, D., Tyson, K.L., et al., Expression of mineralization-regulating proteins in association with human vascular calcification, Z. Kardiol., 2000, vol. 89,suppl. 2, pp. 64–68.
Giachelli, C.M., Vascular calcification mechanisms, J. Am. Soc. Nephrol., 2004, vol. 15, pp. 2959–2964.
Herrmann, S.M., Whatling, C., Brand, E., et al., Polymorphisms of the human matrix Gla protein, MGP0 gene, vascular calcification, and myocardial infarction, Arterioscler. Thromb. Vasc. Biol., 2000, vol. 20, pp. 2386–2393.
Farzaneh-Far, A., Davies, J.D., Braam, L.A., et al., A polymorphism of the human matrix γ-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels, J. Biol. Chem., 2001, vol. 276, pp. 32466–32473.
Kobayashi, N., Kitazawa, R., Maeda, S., et al., T-138C polymorphism of matrix Gla protein promoter alters its expression but is not directly associated with atherosclerotic vascular calcification, Kobe J. Med. Sci., 2004, vol. 50, pp. 69–81.
Brancaccio, D., Biondi, M.L., Gallieni, M., et al., Matrix Gla protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients, Am. J. Nephrol., 2005, vol. 25, pp. 548–552.
Taylor, B.C., Schreiner, P.J., Doherty, T.M., et al., Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the cardio study, Hum. Genet., 2005, vol. 116, pp. 525–528.
Crosier, M.D., Booth, S.L., Peter, I., et al., Matrix Gla protein polymorphisms are associated with coronary artery calcification, J. Nutr. Sci. Vitaminol., 2009, vol. 55, pp. 59–65.
Garbuzova, V.Yu., Gur’yanova, V.L., Parkhomenko, A.N., et al., The frequency of the allelic variants of the matrix Gla protein (MGP) gene in patients with acute coronary syndrome, Fiziol. Zh., 2011, vol. 57, pp. 16–24.
Adams, H.P., Bendixen, B.H., Kappelle, L.J., et al., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment, Stroke, 1993, vol. 24, pp. 35–41.
Abedin, M., Tintut, Y., and Demer, L.L., Vascular calcification. Mechanisms and clinical ramifications, Arterioscler. Thromb. Vasc. Biol., 2004, vol. 24, pp. 1161–1170.
Doherty, T.M., Fitzpatrick, L.A., Inoue, D., et al., Molecular, endocrine, and genetic mechanisms of arterial calcification, Endocrine Rev., 2004, vol. 25, pp. 629–672.
Guzman, R.J., Clinical, cellular, and molecular aspects of arterial calcification, J. Vasc. Surg., 2007, vol. 45, Suppl. A, pp. A57–A63.
Jayalath, R.W., Mangan, S.H., and Golledge, J., Aortic calcification, Eur. J. Endovasc. Surg., 2005, vol. 30, pp. 476–488.
Johnson, R.C., Leopold, J.A., and Loscalzo, J., Vascular calcification. pathobiological mechanisms and clinical implications, Circ. Res., 2006, vol. 99, pp. 1044–1059.
Braam, L.A., Dissel, P., Gijsbers, B.L., et al., Assay for human matrix Gla protein in serum. Potential applications in the cardiovascular fields, Arterioscler. Thromb. Vasc. Biol., 2000, vol. 20, pp. 1257–1261.
Jono, S., Vermeer, C., Dissel, P., et al., Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography, Thromb. Haemost., 2004, vol. 91, pp. 790–794.
Donnell, C.J., Kyla, SheaM., Price, P.A., et al., Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification, Arteriosckler. Thromb. Vasc. Biol., 2006, vol. 26, pp. 2769–2774.
Bos, D., Ikram, M.A., Elias-Smale, S.E., et al., Calcification in major vessel beds relates to vascular brain disease, Arterioscler. Thromb. Vasc. Biol., 2011, vol. 31, pp. 2331–2337.
Acar, A., Cevik, M.U., Arkanoglu, A., et al., Serum levels of calcification inhibitors in patients with intracerebral hemorrhage, Int. J. Neurosci., 2012, vol. 122, pp. 227–232.
Kubo, M., Genetic risk factors of ischemic stroke identified by a genome-wide association study, Brain Nerve, 2008, vol. 60, pp. 1339–1346.
Debette, S. and Sechardi, S., Genetics of atherothrombotic and lacunare stroke, Circ. Cardiovasc. Gen., 2009, vol. 2, pp. 191–198.
Matarin, M., Brown, W.M., Dena, H., et al., Candidate gene polymorphisms for ischemic stroke, Stroke, 2009, vol. 40, pp. 3436–3442.
Wang, X., Cheng, S., Brophy, V.H., et al., A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients, Stroke, 2009, vol. 40, pp. 683–695.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Ukrainian Text © A.V. Ataman, A.V. Polonikov, V.Yu. Garbusova, Yu.A. Ataman, O.I. Matlaj, 2013, published in Tsitologiya i Genetika, 2013, Vol. 47, No. 5, pp. 33–40.
About this article
Cite this article
Ataman, A.V., Polonikov, A.V., Garbusova, V.Y. et al. Analysis of the association of the G-7A polymorphism of the matrix Gla protein gene with ischemic atherothrombotic stroke in humans with its different risk factors. Cytol. Genet. 47, 287–293 (2013). https://doi.org/10.3103/S0095452713050034
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0095452713050034